Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) was $2.75 for the day, down -1.08% from the previous closing price of $2.78. In other words, the price has decreased by -$1.08 from its previous closing price. On the day, 2.54 million shares were traded. ZNTL stock price reached its highest trading level at $3.06 during the session, while it also had its lowest trading level at $2.74.
Ratios:
Our analysis of ZNTL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.29 and its Current Ratio is at 7.29. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On June 20, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $28 to $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 02 ’25 when Lackner Mark sold 4,411 shares for $3.12 per share. The transaction valued at 13,762 led to the insider holds 191,317 shares of the business.
Diana Hausman bought 9,888 shares of ZNTL for $28,294 on Oct 31 ’24. On Oct 04 ’24, another insider, Vultaggio Vincent, who serves as the Principal Accounting Officer of the company, sold 1,603 shares for $3.18 each. As a result, the insider received 5,098 and left with 33,855 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZNTL now has a Market Capitalization of 195979856 and an Enterprise Value of -152006144. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.83 while its Price-to-Book (P/B) ratio in mrq is 0.55. Its current Enterprise Value per Revenue stands at -3.748 whereas that against EBITDA is 0.731.
Stock Price History:
The Beta on a monthly basis for ZNTL is 1.86, which has changed by -0.79446936 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, ZNTL has reached a high of $18.07, while it has fallen to a 52-week low of $2.66. The 50-Day Moving Average of the stock is -16.98%, while the 200-Day Moving Average is calculated to be -54.50%.
Shares Statistics:
ZNTL traded an average of 1.28M shares per day over the past three months and 1490120 shares per day over the past ten days. A total of 71.15M shares are outstanding, with a floating share count of 56.61M. Insiders hold about 19.16% of the company’s shares, while institutions hold 83.17% stake in the company. Shares short for ZNTL as of 1734048000 were 5498855 with a Short Ratio of 3.54, compared to 1731628800 on 4966514. Therefore, it implies a Short% of Shares Outstanding of 5498855 and a Short% of Float of 15.529999.
